商业-话题@MedSci

#商业#

128篇内容 | 2922人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1771803, encodeId=aed81e71803eb, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=超10款产品获批，商业化待定，干细胞治疗是挣钱利器还是救世英雄？, objectType=article, longId=183432, objectId=e1c118343277, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1c118343277, replyNumber=0, likeNumber=86, createdTime=2020-07-27, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1c118343277, moduleTitle=超10款产品获批，商业化待定，干细胞治疗是挣钱利器还是救世英雄？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1c118343277)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771816, encodeId=c3411e71816b7, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=零氪科技已完成7亿元D+轮融资，全面加速重疾“医-药-险”商业闭环落地, objectType=article, longId=200420, objectId=c7de20042053, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7de20042053, replyNumber=0, likeNumber=73, createdTime=2020-12-30, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7de20042053, moduleTitle=零氪科技已完成7亿元D+轮融资，全面加速重疾“医-药-险”商业闭环落地, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7de20042053)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771805, encodeId=8a491e718057d, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=沃比医疗与德国Phenox达成全面商业化合作，惠及全球脑卒中患者, objectType=article, longId=184659, objectId=f9e9184659cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9e9184659cd, replyNumber=0, likeNumber=58, createdTime=2020-03-30, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9e9184659cd, moduleTitle=沃比医疗与德国Phenox达成全面商业化合作，惠及全球脑卒中患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9e9184659cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771809, encodeId=e85f1e7180963, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=针对PD-1和CTLA-4之外的新型免疫检查点抑制剂VISTA，Curis收购抗VISTA抗体并准备将其商业化, objectType=article, longId=185938, objectId=cf49185938ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf49185938ae, replyNumber=0, likeNumber=62, createdTime=2020-07-10, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf49185938ae, moduleTitle=针对PD-1和CTLA-4之外的新型免疫检查点抑制剂VISTA，Curis收购抗VISTA抗体并准备将其商业化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf49185938ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771804, encodeId=49e61e7180452, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=7224万！南京医药拟收购这家中国医药商业百强企业70%的股权, objectType=article, longId=184030, objectId=687318403078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=687318403078, replyNumber=0, likeNumber=76, createdTime=2020-02-27, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=687318403078, moduleTitle=7224万！南京医药拟收购这家中国医药商业百强企业70%的股权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=687318403078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771801, encodeId=24331e7180140, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=Nature：日本再生医学的“商业繁荣”，令人担忧, objectType=article, longId=180301, objectId=3c0d1803015d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c0d1803015d, replyNumber=0, likeNumber=67, createdTime=2020-07-01, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c0d1803015d, moduleTitle=Nature：日本再生医学的“商业繁荣”，令人担忧, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c0d1803015d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771800, encodeId=5dc61e7180085, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=先声药业与JWP宣布在中国联合开发和商业化抗痛风新药, objectType=article, longId=180180, objectId=c84118018060, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c84118018060, replyNumber=0, likeNumber=62, createdTime=2020-01-05, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c84118018060, moduleTitle=先声药业与JWP宣布在中国联合开发和商业化抗痛风新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c84118018060)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771796, encodeId=98ff1e7179642, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=英国推出抗生素创新商业模式政府先采购企业再开发, objectType=article, longId=175440, objectId=81261e5440de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81261e5440de, replyNumber=0, likeNumber=60, createdTime=2020-03-03, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81261e5440de, moduleTitle=英国推出抗生素创新商业模式政府先采购企业再开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81261e5440de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771802, encodeId=11af1e7180217, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=德国模式+张江制造：跨国药企在华生物制药商业化合同生产（CMO）服务平台亮相进博会, objectType=article, longId=182498, objectId=46e01824984a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46e01824984a, replyNumber=0, likeNumber=69, createdTime=2020-03-10, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46e01824984a, moduleTitle=德国模式+张江制造：跨国药企在华生物制药商业化合同生产（CMO）服务平台亮相进博会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46e01824984a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771808, encodeId=199c1e718080e, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=联合家庭医生、用好商业健康保险，民营医院在新医改大有作为, objectType=article, longId=185852, objectId=5e6a185852b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e6a185852b0, replyNumber=0, likeNumber=72, createdTime=2020-05-21, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e6a185852b0, moduleTitle=联合家庭医生、用好商业健康保险，民营医院在新医改大有作为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e6a185852b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771798, encodeId=99e11e71798e7, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=120天严打医药商业贿赂开始了, objectType=article, longId=177354, objectId=1b1e1e73546b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b1e1e73546b, replyNumber=0, likeNumber=76, createdTime=2019-09-24, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b1e1e73546b, moduleTitle=120天严打医药商业贿赂开始了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b1e1e73546b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771795, encodeId=c41d1e7179573, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=首次发布！耗材商业贿赂被重创, objectType=article, longId=168637, objectId=d79c16863e5b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d79c16863e5b, replyNumber=0, likeNumber=52, createdTime=2019-11-17, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d79c16863e5b, moduleTitle=首次发布！耗材商业贿赂被重创, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d79c16863e5b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771797, encodeId=df941e71797fd, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=Clinica Chimica Acta：中国汉族系统性硬化症人群自身抗体商业免疫试剂的评价, objectType=article, longId=177025, objectId=6d051e7025ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d051e7025ac, replyNumber=0, likeNumber=69, createdTime=2020-04-04, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d051e7025ac, moduleTitle=Clinica Chimica Acta：中国汉族系统性硬化症人群自身抗体商业免疫试剂的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d051e7025ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771806, encodeId=26231e71806f8, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=这3款PD-1进入佛山商业补充医保, objectType=article, longId=185202, objectId=d1621852026b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1621852026b, replyNumber=0, likeNumber=79, createdTime=2020-08-10, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1621852026b, moduleTitle=这3款PD-1进入佛山商业补充医保, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1621852026b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771791, encodeId=00dd1e717917f, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=Coherus宣布与AbbVie达成全球和解，确保其Adalimumab生物仿制药CHS-1420商业化的权利, objectType=article, longId=159211, objectId=6a41159211ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a41159211ca, replyNumber=0, likeNumber=54, createdTime=2019-04-13, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a41159211ca, moduleTitle=Coherus宣布与AbbVie达成全球和解，确保其Adalimumab生物仿制药CHS-1420商业化的权利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a41159211ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771799, encodeId=259b1e7179915, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=平安健康（检测）中心获“2019中国健康产业商业模式创新奖” 董事长方蔚豪获评健康中国形象大使称号, objectType=article, longId=178250, objectId=ccc91e825035, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccc91e825035, replyNumber=0, likeNumber=64, createdTime=2019-12-06, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccc91e825035, moduleTitle=平安健康（检测）中心获“2019中国健康产业商业模式创新奖” 董事长方蔚豪获评健康中国形象大使称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccc91e825035)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771789, encodeId=1f211e7178992, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=ARCH PATHOL LAB MED：商业实验室检测进入护理服务系统对儿童保健系统的影响, objectType=article, longId=156964, objectId=1c2a15696475, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c2a15696475, replyNumber=0, likeNumber=59, createdTime=2019-01-18, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c2a15696475, moduleTitle=ARCH PATHOL LAB MED：商业实验室检测进入护理服务系统对儿童保健系统的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c2a15696475)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771794, encodeId=3e251e71794e7, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=受制于支付方和服务体系健康管理商业化的挑战, objectType=article, longId=166971, objectId=77401669e183, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77401669e183, replyNumber=0, likeNumber=70, createdTime=2020-04-28, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77401669e183, moduleTitle=受制于支付方和服务体系健康管理商业化的挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77401669e183)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771793, encodeId=456d1e71793aa, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=医保账户结余资金，可购商业健康保险, objectType=article, longId=163624, objectId=86df163624c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86df163624c0, replyNumber=0, likeNumber=69, createdTime=2019-12-25, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86df163624c0, moduleTitle=医保账户结余资金，可购商业健康保险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86df163624c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771792, encodeId=aaed1e7179274, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=GSK消费保健品与阿里健康签署联合商业计划共绘电商新蓝图, objectType=article, longId=163588, objectId=5ea516358846, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ea516358846, replyNumber=0, likeNumber=60, createdTime=2020-01-17, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ea516358846, moduleTitle=GSK消费保健品与阿里健康签署联合商业计划共绘电商新蓝图, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ea516358846)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

商业

2020-05-29

zhangxingru (审核中...)

前往app查看评论内容

#商业#

超10款产品获批，商业化待定，干细胞治疗是挣钱利器还是救世英雄？

2020-07-27

zhangxingru (审核中...)

前往app查看评论内容

#商业#

零氪科技已完成7亿元D+轮融资，全面加速重疾“医-药-险”商业闭环落地

2020-12-30

zhangxingru (审核中...)

前往app查看评论内容

#商业#

沃比医疗与德国Phenox达成全面商业化合作，惠及全球脑卒中患者

2020-03-30

zhangxingru (审核中...)

前往app查看评论内容

#商业#

针对PD-1和CTLA-4之外的新型免疫检查点抑制剂VISTA，Curis收购抗VISTA抗体并准备将其商业化

2020-07-10

zhangxingru (审核中...)

前往app查看评论内容

#商业#

7224万！南京医药拟收购这家中国医药商业百强企业70%的股权

2020-02-27

zhangxingru (审核中...)

前往app查看评论内容

#商业#

Nature：日本再生医学的“商业繁荣”，令人担忧

2020-07-01

zhangxingru (审核中...)

前往app查看评论内容

#商业#

先声药业与JWP宣布在中国联合开发和商业化抗痛风新药

2020-01-05

zhangxingru (审核中...)

前往app查看评论内容

#商业#

英国推出抗生素创新商业模式政府先采购企业再开发

2020-03-03

zhangxingru (审核中...)

前往app查看评论内容

#商业#

德国模式+张江制造：跨国药企在华生物制药商业化合同生产（CMO）服务平台亮相进博会

2020-03-10

zhangxingru (审核中...)

前往app查看评论内容

#商业#

联合家庭医生、用好商业健康保险，民营医院在新医改大有作为

2020-05-21

zhangxingru (审核中...)

前往app查看评论内容

#商业#

120天严打医药商业贿赂开始了

2019-09-24

zhangxingru (审核中...)

前往app查看评论内容

#商业#

首次发布！耗材商业贿赂被重创

2019-11-17

zhangxingru (审核中...)

前往app查看评论内容

#商业#

Clinica Chimica Acta：中国汉族系统性硬化症人群自身抗体商业免疫试剂的评价

2020-04-04

zhangxingru (审核中...)

前往app查看评论内容

#商业#

这3款PD-1进入佛山商业补充医保

2020-08-10

zhangxingru (审核中...)

前往app查看评论内容

#商业#

Coherus宣布与AbbVie达成全球和解，确保其Adalimumab生物仿制药CHS-1420商业化的权利

2019-04-13

zhangxingru (审核中...)

前往app查看评论内容

#商业#

平安健康（检测）中心获“2019中国健康产业商业模式创新奖” 董事长方蔚豪获评健康中国形象大使称号

2019-12-06

zhangxingru (审核中...)

前往app查看评论内容

#商业#

ARCH PATHOL LAB MED：商业实验室检测进入护理服务系统对儿童保健系统的影响

2019-01-18

zhangxingru (审核中...)

前往app查看评论内容

#商业#

受制于支付方和服务体系健康管理商业化的挑战

2020-04-28

zhangxingru (审核中...)

前往app查看评论内容

#商业#

医保账户结余资金，可购商业健康保险

2019-12-25

zhangxingru (审核中...)

前往app查看评论内容

#商业#

GSK消费保健品与阿里健康签署联合商业计划共绘电商新蓝图

2020-01-17

科室
- - 订阅+
  - 更多科室
工具
服务